Big Money Sentiment increased to 1.07 in Q3 2018. It has change of 0.09, from 2018Q2’s 0.98. The ratio increased due to MDT positioning: 24 sold and 440 reduced. 140 funds bought holdings and 355 increased holdings. Investors holded 1.03 billion in 2018Q2 but now own 1.02 billion shares or 0.96% less. Hexavest holds 1.16M shs or 1.46% of its capital. Cleararc owns 37,387 shs for 0.48% of their capital. Perigon Wealth Mngmt Limited Liability holds 0.08% or 3,175 shs. Destination Wealth Mgmt has invested 0.01% in Medtronic plc (NYSE:MDT). Foyston Gordon Payne reported 8.13% stake. Mcdaniel Terry reported 6,593 shs or 0.11% of all its holdings. Polaris Greystone Gru Ltd Liability has 1,321 shs. 533,275 are owned by Davenport Limited Company. Boston Family Office Ltd owns 0.09% invested in Medtronic plc (NYSE:MDT) for 8,698 shs. Smithfield Trust Com holds 8,833 shs. 7,218 are owned by Charter Tru. Of Oklahoma holds 0% or 22,550 shs in its capital. Cap Planning Limited Liability Corporation accumulated 4,500 shs. Menora Mivtachim holds 457,655 shs or 1.22% of its capital. The Texas-based Next Fincl Gp has invested 0.09% in Medtronic plc (NYSE:MDT).
Based on the latest 2018Q3 regulatory filing with the SEC, Strs Ohio reduced its holdings in Medtronic Inc (MDT) by 4.79%. By selling 77,541 shares Strs Ohio made the stock sank with 0.92%. The institutional investor is holding 1.54M shares, compared to the 1.62 million from the previous quarter. And the announced value of the electromedical & electrotherapeutic apparatus company is $151.50 million for the 2018Q3. Medtronic Inc has $123.46 billion MC. MDT reached $92.09 during the last trading session after $1.59 change.Medtronic plc has 8.02M shares volume, 30.17% up from normal. MDT is uptrending and has moved 18.51% since March 3, 2018. MDT outperformed the S&P500 by 18.51%.
About $22.80 billion US Long portfolio Strs Ohio operates. It rose its stake in Halliburton Company (NYSE:HAL) by 141,784 shares to 1.81 million shares, valued at $73.51 million in 2018Q3, according to the filing. Strs Ohio has risen its stake in First Horizon National Corporation (NYSE:FHN) and also increased its holding in Ppl Corporation (NYSE:PPL) by 141,999 shares in the quarter, for a total of 1.85 million shares.
For more Medtronic plc (NYSE:MDT) news published recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “FDA OKs expanded use for Medtronic’s Resolute DES – Seeking Alpha” published on February 26, 2019, “FDA clears Medtronic nerve ablation platform – Seeking Alpha” on February 27, 2019, “Medtronic Q3 2018 Earnings Preview – Seeking Alpha” with a publish date: February 18, 2019, “Medtronic DBM bone graft launched in Japan – Seeking Alpha” and the last “Medtronic issues Class I recall of pulse generators – Seeking Alpha” with publication date: February 15, 2019.
Medtronic plc (NYSE:MDT) Ratings Coverage
A total of 12 analysts rate Medtronic (NYSE:MDT) as follows: 9 “Buy”, 3 “Hold” and 0 “Sell”. Š¢herefore 75% are bullish. (NYSE:MDT) has 19 ratings reports on Mar 3, 2019 according to StockzIntelligence. On Wednesday, December 19 JP Morgan upgraded the shares of MDT in report to “Overweight” rating. On Wednesday, January 2 the firm earned “Equal-Weight” rating by Morgan Stanley. On Wednesday, February 20 the stock has “Buy” rating by Credit Suisse. On Monday, February 25 Citigroup maintained Medtronic plc (NYSE:MDT) rating. Citigroup has “Neutral” rating and $101 target. On Wednesday, November 21 the company was maintained by Raymond James. In Wednesday, January 2 report Citigroup downgraded the stock to “Neutral” rating. The stock rating was maintained by Argus Research with “Buy” on Monday, October 8. On Wednesday, February 20 the company was maintained by Northland Capital. On Tuesday, February 19 the firm earned “Buy” rating by Barclays Capital. On Tuesday, January 8 Barclays Capital maintained Medtronic plc (NYSE:MDT) with “Overweight” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.